KPL3,520.00

Kwality Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOC
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Returns
Return on Assets35.03
Return on Capital Employed19.6719.18
Return on Invested Capital10.91
Margins
EBITDA Margin37.6524.0221.69
Operating Margin35.3118.0815.34
Incremental Operating Margin56.413.12
Pretax Margin35.4410.2610.24
Net Income Margin26.32
FCF Margin1.73-2.19
Additional
Effective Tax Rate25.53
Incremental Operating Margin %56.413.12
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.